Four things to know:
1. 4CIS Chiron is designed for use in all surgery methods including mono- and poly cannula procedures, reduction and minimally invasive surgery.
2. The device aims to prevent pull-out after surgery.
3. CEO of Solis Biomedical Kim Il expects the launch to “increase sales for the company globally.”
4. Solco Biomedical plans to market 4CIS Chiron in the U.S. and Korea in September.
More articles on devices:
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure
The big trends, issues in spine shaping practices today
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.